Trigon acted as Sole Global Coordinator and Sole Bookrunner in the PLN 64 million Accelerated Bookbuilding (ABB) for Scope Fluidics S.A.

Trigon successfully completed a PLN 64 million Accelerated Bookbuilding (ABB) transaction for Scope Fluidics S.A., an innovative medtech company listed on the Warsaw Stock Exchange. As part of the transaction, existing shares were borrowed by Trigon Investment Banking from the company’s founders and subsequently sold through the ABB process. The proceeds from the sale were used to subscribe for newly issued shares, providing Scope Fluidics with additional capital to strengthen its financial position and support the ongoing development of its diagnostic technology projects. The transaction featured an innovative structure – the first of its kind for Trigon – in which Trigon Investment Banking acted as an intermediate investor to facilitate the efficient execution of the offering. The deal attracted strong investor interest and marks an important milestone in Scope Fluidics’ continued growth and expansion within the life science and diagnostics sector.